The two different receptors for tumor necrosis factor mediate distinct cellular responses - PubMed (original) (raw)

The two different receptors for tumor necrosis factor mediate distinct cellular responses

L A Tartaglia et al. Proc Natl Acad Sci U S A. 1991.

Abstract

The individual roles of the murine type 1 and type 2 tumor necrosis factor (TNF) receptors (TNF-R1 and TNF-R2) were investigated utilizing (i) the strong species specificity of TNF-R2 for murine TNF compared to human TNF and (ii) agonistic rabbit polyclonal antibodies directed against the individual TNF receptors. Proliferation of mouse thymocytes and the murine cytotoxic T-cell line CT-6 is stimulated by murine TNF but not by human TNF. Consistent with this observation, polyclonal antibodies directed against TNF-R2 induced proliferation in both of these cell types, whereas polyclonal antibodies directed against TNF-R1 had no effect. In contrast, cytotoxicity in murine LM cells (which are sensitive to murine and human TNF) was induced by antibodies against TNF-R1 but not by antibodies against TNF-R2. Also, the steady-state level of manganous superoxide dismutase mRNA in the murine NIH 3T3 cell line was induced by murine TNF, human TNF, and anti-TNF-R1 but not by anti-TNF-R2. These results suggest that TNF-R2 initiates signals for the proliferation of thymocytes and cytotoxic T cells, whereas TNF-R1 initiates signals for cytotoxicity and the induction of the protective activity, manganous superoxide dismutase. The nonredundant signaling observed for the two TNF receptors cannot be explained simply by the differential expression of the two TNF receptors in the various cell types, because LM cells express on their surface higher levels of TNF-R2 than TNF-R1, and LM cells, NIH 3T3 cells, and thymus cells all express mRNA corresponding to both receptor types. It is therefore likely that the two receptors initiate distinct signaling pathways that result in the induction of different cellular responses.

PubMed Disclaimer

Similar articles

• Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor.
  Tartaglia LA, Goeddel DV, Reynolds C, Figari IS, Weber RF, Fendly BM, Palladino MA Jr. Tartaglia LA, et al. J Immunol. 1993 Nov 1;151(9):4637-41. J Immunol. 1993. PMID: 8409424
• Antiviral activity of tumor necrosis factor is signaled through the 55-kDa type I TNF receptor [corrected].
  Wong GH, Tartaglia LA, Lee MS, Goeddel DV. Wong GH, et al. J Immunol. 1992 Nov 15;149(10):3350-3. J Immunol. 1992. PMID: 1331233
• Tumor necrosis factor (TNF) stimulates the production of nerve growth factor in fibroblasts via the 55-kDa type 1 TNF receptor.
  Hattori A, Hayashi K, Kohno M. Hattori A, et al. FEBS Lett. 1996 Jan 29;379(2):157-60. doi: 10.1016/0014-5793(95)01502-7. FEBS Lett. 1996. PMID: 8635583
• Tumor necrosis factor: receptor binding and mitogenic action in fibroblasts.
  Vilcek J, Tsujimoto M, Palombella VJ, Kohase M, Le J. Vilcek J, et al. J Cell Physiol Suppl. 1987;Suppl 5:57-61. doi: 10.1002/jcp.1041330412. J Cell Physiol Suppl. 1987. PMID: 2824534 Review.
• TNF receptor distribution in human tissues.
  Ryffel B, Mihatsch MJ. Ryffel B, et al. Int Rev Exp Pathol. 1993;34 Pt B:149-56. doi: 10.1016/b978-0-12-364935-5.50015-8. Int Rev Exp Pathol. 1993. PMID: 8384611 Review.

Cited by

• Tumor necrosis factor receptor 2 promotes endothelial cell-mediated suppression of CD8+ T cells through tuning glycolysis in chemoresistance of breast cancer.
  Hu Y, Lou X, Zhang K, Pan L, Bai Y, Wang L, Wang M, Yan Y, Wan J, Yao X, Duan X, Ni C, Qin Z. Hu Y, et al. J Transl Med. 2024 Jul 20;22(1):672. doi: 10.1186/s12967-024-05472-5. J Transl Med. 2024. PMID: 39033271 Free PMC article.
• Cellular heterogeneity in TNF/TNFR1 signalling: live cell imaging of cell fate decisions in single cells.
  Preedy MK, White MRH, Tergaonkar V. Preedy MK, et al. Cell Death Dis. 2024 Mar 11;15(3):202. doi: 10.1038/s41419-024-06559-z. Cell Death Dis. 2024. PMID: 38467621 Free PMC article. Review.
• Selective Inhibition of Soluble Tumor Necrosis Factor Alters the Neuroinflammatory Response following Moderate Spinal Cord Injury in Mice.
  Lund MC, Ellman DG, Nielsen PV, Raffaele S, Fumagalli M, Guzman R, Degn M, Brambilla R, Meyer M, Clausen BH, Lambertsen KL. Lund MC, et al. Biology (Basel). 2023 Jun 12;12(6):845. doi: 10.3390/biology12060845. Biology (Basel). 2023. PMID: 37372129 Free PMC article.
• Tumor Necrosis Factor Family Members and Myocardial Ischemia-Reperfusion Injury: State of the Art and Therapeutic Implications.
  Galeone A, Grano M, Brunetti G. Galeone A, et al. Int J Mol Sci. 2023 Feb 27;24(5):4606. doi: 10.3390/ijms24054606. Int J Mol Sci. 2023. PMID: 36902036 Free PMC article. Review.
• It's ok to be outnumbered - sub-stoichiometric modulation of homomeric protein complexes.
  Dimitrova YN, Gutierrez JA, Huard K. Dimitrova YN, et al. RSC Med Chem. 2022 Oct 27;14(1):22-46. doi: 10.1039/d2md00212d. eCollection 2023 Jan 25. RSC Med Chem. 2022. PMID: 36760737 Free PMC article. Review.

References

1. 1. J Immunol. 1991 May 1;146(9):3045-8 - PubMed
2. 1. Proc Natl Acad Sci U S A. 1975 Sep;72(9):3666-70 - PubMed
3. 1. J Biol Chem. 1990 Dec 25;265(36):22409-17 - PubMed
4. 1. J Exp Med. 1990 Nov 1;172(5):1517-20 - PubMed
5. 1. J Clin Invest. 1988 Feb;81(2):455-60 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database